These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 26498258)

  • 1. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study.
    Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F
    Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pacing site characteristics on response to cardiac resynchronization therapy.
    Wong JA; Yee R; Stirrat J; Scholl D; Krahn AD; Gula LJ; Skanes AC; Leong-Sit P; Klein GJ; McCarty D; Fine N; Goela A; Islam A; Thompson T; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Jul; 6(4):542-50. PubMed ID: 23741053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.
    Leyva F; Foley PW; Chalil S; Ratib K; Smith RE; Prinzen F; Auricchio A
    J Cardiovasc Magn Reson; 2011 Jun; 13(1):29. PubMed ID: 21668964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular scar impact on left ventricular synchronization parameters and outcomes of cardiac resynchronization therapy.
    Ahmed W; Samy W; Tayeh O; Behairy N; Abd El Fattah A
    Int J Cardiol; 2016 Nov; 222():665-670. PubMed ID: 27517660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling.
    Shetty AK; Duckett SG; Ginks MR; Ma Y; Sohal M; Bostock J; Kapetanakis S; Singh JP; Rhode K; Wright M; O'Neill MD; Gill JS; Carr-White G; Razavi R; Rinaldi CA
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):692-9. PubMed ID: 23175695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of left ventricular lead position related to regional scar by speckle-tracking echocardiography with clinical outcomes in patients receiving cardiac resynchronization therapy.
    Sade LE; Saba S; Marek JJ; Onishi T; Schwartzman D; Adelstein EC; Soman P; Gorcsan J
    J Am Soc Echocardiogr; 2014 Jun; 27(6):648-56. PubMed ID: 24637058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LV cathode position in CRT recipients: How can we benefit from CMR?
    Bertelli M; Ziacchi M; van Slochteren F; Rondanina E; Lazzeri M; Carecci A; Biffi M
    Int J Cardiol; 2024 Oct; 412():132321. PubMed ID: 38977225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy.
    Chen Z; Sohal M; Sammut E; Child N; Jackson T; Claridge S; Cooklin M; O'Neill M; Wright M; Gill J; Chiribiri A; Schaeffter T; Carr-White G; Razavi R; Rinaldi CA
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):203-9. PubMed ID: 26463874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for left ventricular lead placement in cardiac resynchronization therapy: Intraprocedural integration of coronary venous electroanatomic mapping with delayed enhancement cardiac magnetic resonance imaging.
    Nguyên UC; Mafi-Rad M; Aben JP; Smulders MW; Engels EB; van Stipdonk AM; Luermans JG; Bekkers SC; Prinzen FW; Vernooy K
    Heart Rhythm; 2017 Jan; 14(1):110-119. PubMed ID: 27663606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging assessment of intraventricular dyssynchrony and delayed enhancement as predictors of response to cardiac resynchronization therapy in patients with heart failure of ischaemic and non-ischaemic etiologies.
    Petryka J; Miśko J; Przybylski A; Śpiewak M; Małek ŁA; Werys K; Mazurkiewicz Ł; Gepner K; Croisille P; Demkow M; Rużyłło W
    Eur J Radiol; 2012 Oct; 81(10):2639-47. PubMed ID: 22056486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between radial strain evaluation by speckle-tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy.
    Bakos Z; Ostenfeld E; Markstad H; Werther-Evaldsson A; Roijer A; Arheden H; Carlsson M; Borgquist R
    Europace; 2014 Dec; 16(12):1779-86. PubMed ID: 25031235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging left-ventricular mechanical activation in heart failure patients using cine DENSE MRI: Validation and implications for cardiac resynchronization therapy.
    Auger DA; Bilchick KC; Gonzalez JA; Cui SX; Holmes JW; Kramer CM; Salerno M; Epstein FH
    J Magn Reson Imaging; 2017 Sep; 46(3):887-896. PubMed ID: 28067978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study.
    Huntjens PR; Walmsley J; Ploux S; Bordachar P; Prinzen FW; Delhaas T; Lumens J
    Europace; 2014 Nov; 16 Suppl 4():iv62-iv68. PubMed ID: 25362172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.
    Sommer A; Kronborg MB; Nørgaard BL; Stephansen C; Poulsen SH; Kristensen J; Gerdes C; Nielsen JC
    Europace; 2018 Oct; 20(10):1630-1637. PubMed ID: 29377984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.